AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 61(2), 1999, pp. 245-248
Copyright © 1999 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rallon, N.
Right arrow Articles by Giraldo, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rallon, N.
Right arrow Articles by Giraldo, L.
Related Collections
Right arrow Plasmodium
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 61, Issue 2, 245-248
Copyright © 1999 by American Society of Tropical Medicine and Hygiene

Research Articles


Lack of an association between the ASN-108 mutation in the dihydrofolate reductase gene and in vivo resistance to sulfadoxine/pyrimethamine in Plasmodium falciparum

NI Rallon, LE Osorio, and LE Giraldo

Sulfadoxine/pyrimethamine (SP) is considered an alternative treatment for acute uncomplicated malaria caused by Plasmodium falciparum resistant to chloroquine. However, the appearance of resistance to this drug has been reported since its initial use in Colombia. Molecular analysis of the dihydrofolate reductase gene indicates a correlation between in vitro resistance to SP and the Asn-108 point mutation. Little is known about the association of this point mutation and in vivo resistance to SP. We used a mutation-specific polymerase chain reaction strategy to analyze the presence of the Asn-108 point mutation in 48 clinical samples with adequate clinical response (ACR), 2 early treatment failures (ETF), and 1 late treatment failure (LTF). The Asn-108 mutation was detected in 36 of the ACR samples and in all of the ETF and LTF samples. Eleven ACR samples amplified with the wild-type-specific primer and one amplified with the primer for the Thr-108 mutation described for resistance to cycloguanil. These results suggest that the Asn-108 marker may not be useful in predicting SP treatment failure.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
K. MUGITTU, M. NDEJEMBI, A. MALISA, M. LEMNGE, Z. PREMJI, A. MWITA, W. NKYA, J. KATARAIHYA, S. ABDULLA, H.-P. BECK, et al.
THERAPEUTIC EFFICACY OF SULFADOXINE-PYRIMETHAMINE AND PREVALENCE OF RESISTANCE MARKERS IN TANZANIA PRIOR TO REVISION OF MALARIA TREATMENT POLICY: PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE AND DIHYDROPTEROATE SYNTHASE MUTATIONS IN MONITORING IN VIVO RESISTANCE
Am J Trop Med Hyg, December 1, 2004; 71(6): 696 - 702.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
G. DORSEY, C. DOKOMAJILAR, M. KIGGUNDU, S. G. STAEDKE, M. R. KAMYA, and P. J. ROSENTHAL
PRINCIPAL ROLE OF DIHYDROPTEROATE SYNTHASE MUTATIONS IN MEDIATING RESISTANCE TO SULFADOXINE-PYRIMETHAMINE IN SINGLE-DRUG AND COMBINATION THERAPY OF UNCOMPLICATED MALARIA IN UGANDA
Am J Trop Med Hyg, December 1, 2004; 71(6): 758 - 763.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
M. ALIFRANGIS, S. ENOSSE, I. F. KHALIL, D. S. TARIMO, M. M. LEMNGE, R. THOMPSON, I. C. BYGBJERG, and A. M. RONN
PREDICTION OF PLASMODIUM FALCIPARUM RESISTANCE TO SULFADOXINE/ PYRIMETHAMINE IN VIVO BY MUTATIONS IN THE DIHYDROFOLATE REDUCTASE AND DIHYDROPTEROATE SYNTHETASE GENES: A COMPARATIVE STUDY BETWEEN SITES OF DIFFERING ENDEMICITY
Am J Trop Med Hyg, December 1, 2003; 69(6): 601 - 606.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society of Tropical Medicine and Hygiene.